// App-Quantinova.ai

ABS207 : USE OF DESMOPRESSIN IN THE TREATMENT OF BLEEDING IN NON‐SEVERE HEMOPHILIA A

Researchers

Presenter

  • F. R. Kloosterman

Principal Investigators

  • A.-F. Zwagemaker

  • S. C. Gouw

  • E. A. M. Beckers

  • S. Boyce

  • P. Collins

  • J. Eikenboom

  • K. Fischer

  • S. Jackson

  • M. J. H. A. Kruip

  • B. Laros-van Gorkum

  • L. Nieuwenhuizen

  • I. Pabinger

  • M. Coppens

  • J. G. van der Bom

  • G. Castaman

  • K. Fijnvandraat

Medical Centers

  • Paediatric Cardiology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

  • Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands

  • Department of Medical Oncology, Maastricht University Medical Center, Maastricht, Netherlands

  • Department of Haematology, University Hospital Southampton, Southampton

  • Arthur Bloom Haemophilia Centre, University Hospital of Wales School of Medicine, Cardiff, United Kingdom

  • Department of Internal Medicine, division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden

  • Hematology and Van Creveld Cinic, University Medical Center Utrecht, Utrecht, Netherlands

  • Inherited Bleeding Disorders Program of BC ‐ Adult Division, St. Paul’s Hospital Vancouver British Columbia, Vancouver, Canada

  • Department of Hematology,Amsterdam University Medical Center, AMC,Amsterdam,Niederlande

  • Department of Rheumatology, Radboud University Nijmegen Medical Centre, Netherlands

  • Gastroenterology, Maxima Medical Center, Eindhoven, Netherlands

  • Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria

  • Department of Vascular Medicine, Amsterdam University Medical Centres, Amsterdam

  • Center for Clinical Transfusion Research, Sanquin‐Leiden University Medical Center, Leiden, Netherlands

  • Department of Oncology, Center for Bleeding Disorders, Careggi University Hospital, Florence, Italy

  • Molecular Cellular Hemostasis, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands

Locations

  • Netherlands

  • United Kingdom

  • Canada

  • Austria

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • Desmopressin

  • FVIII

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • NCT03623295

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved